Sep 30, 2021 / 05:20PM GMT
Jennifer Kim - Cantor Fitzgerald - Analyst
Hello, everyone. I am Jennifer Kim, a large-cap and biopharma analyst here at Cantor. Thank you for joining us today for our virtual fireside chat with Lipocine. Lipocine is a clinical-stage biopharmaceutical company focused on leveraging its proprietary drug delivery technologies to address metabolic and endocrine disorders. And today we are very excited to have with us the CEO, Dr. Mahesh Patel, to discuss the Company's pipeline and the market opportunity for its products.
So, Mahesh, thank you so much for joining us.
Mahesh Patel - Lipocine Inc. - Chairman, President, and CEO
Yes. Thanks, Cantor, and appreciate it, Jennifer, for giving me this opportunity (multiple speakers) story.
Jennifer Kim - Cantor Fitzgerald - Analyst
Yes, I'm excited to discuss. So maybe to start off, for investors that are newer to your story, could you walk us through the history of the Company and how you came to be? And what do you see as the Company's differentiated offering in the
Lipocine Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot